Multi Drug Resistance in Cancer Therapy-An Overview
HARISH KADKOL, Vikas Kumar Jain, AMIT PATIL · Journal of Critical Reviews · 2019
Multidrug resistance is a mechanism by which chemotherapeutic drugs develops resistance in cancer treatment. Multidrug resistance (MDR) is the most essential test to compelling chemotherapeutic efficacy against tumor growth. Improvements in the DNA microarray, proteomics innovation and the outgrowth of focused treatments convey the new ways to deal with the drug resistance in spite the structures of the new chemotherapy drugs. The chemotherapeutic drugs develops multi drug resistance as the drug treats the tumor but the cells tends to shows a resistant effect for the same drug when used again, despite their diverse concoction structure and distinctive mechanism of intracellular activity. The scope of the review explains us about multi drug resistance, the mechanisms of malignant growth inhibiting drugs and overcoming multidrug-resistance. Search Criteria: A literature survey was done in Scopus, PubMed, Google Scholar, and Science Direct database for articles for published articles from 1946 to 2019 on multidrug resistant and its mechanism on cancer